Ron Waksman – författare

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management comprehensively covers COVID-19’s impact on the cardiovascular system. Coverage includes the pathophysiology, clinical manifestations, diagnostic approach, treatment options, and clinical outcomes of patients presenting with COVID-19 with cardiac involvement. In a concise but comprehensive manner, the book's content reviews the epidemiology, risk factors, pathophysiology of COVID-19, cardiovascular clinical manifestations, non-invasive and invasive diagnostic evaluation, therapeutic options, outcomes data, role of the COVID-19 vaccine, and long-term outcomes/management.This is the perfect reference for basic and clinical researchers in cardiovascular medicine as well as practicing clinical cardiologists who are dealing with COVID-19 patients with cardiac involvement.Explains the pathophysiology, clinical manifestations, diagnostic approach, treatment options, and clinical outcomes of patients presenting with COVID-19 and cardiac involvementElucidates new and emerging options to treat this disease processProvides concise, well validated, published data available in one single resource

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management comprehensively covers COVID-19''s impact on the cardiovascular system. Coverage includes the pathophysiology, clinical manifestations, diagnostic approach, treatment options, and clinical outcomes of patients presenting with COVID-19 with cardiac involvement. In a concise but comprehensive manner, the book''s content reviews the epidemiology, risk factors, pathophysiology of COVID-19, cardiovascular clinical manifestations, non-invasive and invasive diagnostic evaluation, therapeutic options, outcomes data, role of the COVID-19 vaccine, and long-term outcomes/management.This is the perfect reference for basic and clinical researchers in cardiovascular medicine as well as practicing clinical cardiologists who are dealing with COVID-19 patients with cardiac involvement.- Explains the pathophysiology, clinical manifestations, diagnostic approach, treatment options, and clinical outcomes of patients presenting with COVID-19 and cardiac involvement- Elucidates new and emerging options to treat this disease process- Provides concise, well validated, published data available in one single resource

With the first coronary balloon angioplasty in 1977 came the challenge of the wound healing process of restenosis. Together these events spawned a new field of medicine, vascular brachytherapy, conceived to resolve this leading complication of vascular intervention. In the ensuing 20 year quest for a cure to restenosis, radiation vascular therapy appears to be the next logical step, but it still needs validation. The new Vascular Brachytherapy, 3rd Edition continues to provide a comprehensive, engaging picture of this rapidly expanding and evolving field. This collaborative effort contains 61 new or revised chapters by renowned experts from a vast range of medical fields, with over one-third more material than previous editions. Scientists, cardiologists, radiation oncologists, radiobiologists, pathologists, vascular surgeons, radiation safety officers, regulators, engineers, and technicians each take turns presenting carefully considered investigations and observations, supplemented with clinical and nonclinical data, basic radiation principles, and issues from an economic, regulatory, and safety perspective. For an audience of clinicians, scientists and researchers from all the represented medical disciplines, this book provides in-depth information and exposure to subjects within these diverse areas of expertise.

Since publication of the First Edition, advances in the diagnosis and prevention and treatment strategies of the vulnerable plaque have necessitated this greatly expanded second edition. With several new chapters covering mainly diagnostic and treatment options, The Handbook of the Vulnerable Plaque will remain the benchmark text for all interventi

Edited by a team of the world’s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents.  This important new book: Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells.Thoroughly covers platelet function testing, including novel techniques.Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease.Reviews all types of antiplatelet agents – from aspirin to recently approved drugs – including indications, clinical outcomes, and side effects.  Written by an international “who’s who” of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists.

Edited by a team of the world’s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents.

 

This important new book:

Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells. Thoroughly covers platelet function testing, including novel techniques. Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease. Reviews all types of antiplatelet agents – from aspirin to recently approved drugs – including indications, clinical outcomes, and side effects.

 

Written by an international “who’s who” of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists.

Edited by a team of the world’s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents.

 

This important new book:

Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells. Thoroughly covers platelet function testing, including novel techniques. Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease. Reviews all types of antiplatelet agents – from aspirin to recently approved drugs – including indications, clinical outcomes, and side effects.

 

Written by an international “who’s who” of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists.

"Chronic total occlusions continue to represent one of the greatest challenges to interventional cardiologists." - Cardiovascular Research Foundation - Chronic Total Occlusions or CTOs can be found in 30% of patients with coronary artery disease. Despite advances, CTOs remain one of the most frequently identified lesions in interventional cardiology yet least likely to be successfully treated. The prevalence of the disorder is vexing. The threat to your patients is significant. The condition is complex. And, treatment remains a challenge. Learn how to approach CTOs from internationally-recognized physician-educators Turn to Chronic Total Occlusions: A Guide to Recanalization, 2e for expert insight into the world of CTOs and clear, practical guidance you can apply directly and immediately in your cath lab. Offering the most comprehensive information available, this completely updated second edition provides you wih:

Full-color images from the diagnostic modalities that are essential in identifying CTOs Data on indications and efficacy from the most recent clinical trials Practical guidance on the selection and use of the latest wires and devices Even more tips and tricks from leading operators from the world’s busiest centers Clinical cases to illustrate some of the more complex scenarios and common complications And more!

Chronic Total Occlusions: A Guide to Recanalization, 2e is the guide you can count on to improve the CTO success rate at your facility. Order your copy today!

"Chronic total occlusions continue to represent one of the greatest challenges to interventional cardiologists." - Cardiovascular Research Foundation - Chronic Total Occlusions or CTOs can be found in 30% of patients with coronary artery disease. Despite advances, CTOs remain one of the most frequently identified lesions in interventional cardiology yet least likely to be successfully treated. The prevalence of the disorder is vexing. The threat to your patients is significant. The condition is complex. And, treatment remains a challenge. Learn how to approach CTOs from internationally-recognized physician-educators Turn to Chronic Total Occlusions: A Guide to Recanalization, 2e for expert insight into the world of CTOs and clear, practical guidance you can apply directly and immediately in your cath lab. Offering the most comprehensive information available, this completely updated second edition provides you wih:

Full-color images from the diagnostic modalities that are essential in identifying CTOs Data on indications and efficacy from the most recent clinical trials Practical guidance on the selection and use of the latest wires and devices Even more tips and tricks from leading operators from the world’s busiest centers Clinical cases to illustrate some of the more complex scenarios and common complications And more!

Chronic Total Occlusions: A Guide to Recanalization, 2e is the guide you can count on to improve the CTO success rate at your facility. Order your copy today!

TRANSCATHETER MITRAL VALVE THERAPIES

An essential survey of the advancing field of transcatheter mitral valve repair and replacement

Minimally invasive transcatheter therapies have revolutionized the treatment of structural heart disease. Greatly improving outcomes for higher-risk patients, transcatheter aortic valve replacement is now established as a safe and effective alternative to invasive surgery. The mitral valve, however, poses further challenges. Contending with one of the heat’s most anatomically and pathologically complex components, practitioners and engineers have yet to perfect a stream-lined, widely deliverable therapy—though they are getting closer and closer to this goal.

Transcatheter Mitral Valve Therapies provides a far-reaching survey of the field of mitral interventions in its current state. Highlighting the stumbling blocks preventing transcatheter mitral valve replacement’s widespread adoption, the book’s international group of contributors discuss the improvements to be made in repair and replacement procedures, as well as the adjunctive use of imaging and pharmacologic therapies. This ground-breaking text:

Provides detailed explanations of transcatheter repair, transcatheter replacement, and adjunctive proceduresFeatures chapters on the use of imaging to aid in patient selection, procedure planning, and intra-operative guidanceDiscusses the importance of minimally invasive approaches for mitral valve repairExamines anticoagulation following transcatheter mitral valve interventionsOutlines the possible future of transcatheter mitral valve therapy

Transcatheter Mitral Valve Therapies is an important, up-to-date resource for interventional cardiologists, as well as all clinical researchers and practitioners seeking information on this vital and developing treatment.

TRANSCATHETER MITRAL VALVE THERAPIES

An essential survey of the advancing field of transcatheter mitral valve repair and replacement

Minimally invasive transcatheter therapies have revolutionized the treatment of structural heart disease. Greatly improving outcomes for higher-risk patients, transcatheter aortic valve replacement is now established as a safe and effective alternative to invasive surgery. The mitral valve, however, poses further challenges. Contending with one of the heat’s most anatomically and pathologically complex components, practitioners and engineers have yet to perfect a stream-lined, widely deliverable therapy—though they are getting closer and closer to this goal.

Transcatheter Mitral Valve Therapies provides a far-reaching survey of the field of mitral interventions in its current state. Highlighting the stumbling blocks preventing transcatheter mitral valve replacement’s widespread adoption, the book’s international group of contributors discuss the improvements to be made in repair and replacement procedures, as well as the adjunctive use of imaging and pharmacologic therapies. This ground-breaking text:

Provides detailed explanations of transcatheter repair, transcatheter replacement, and adjunctive proceduresFeatures chapters on the use of imaging to aid in patient selection, procedure planning, and intra-operative guidanceDiscusses the importance of minimally invasive approaches for mitral valve repairExamines anticoagulation following transcatheter mitral valve interventionsOutlines the possible future of transcatheter mitral valve therapy

Transcatheter Mitral Valve Therapies is an important, up-to-date resource for interventional cardiologists, as well as all clinical researchers and practitioners seeking information on this vital and developing treatment.

TRANSCATHETER MITRAL VALVE THERAPIES An essential survey of the advancing field of transcatheter mitral valve repair and replacementMinimally invasive transcatheter therapies have revolutionized the treatment of structural heart disease. Greatly improving outcomes for higher-risk patients, transcatheter aortic valve replacement is now established as a safe and effective alternative to invasive surgery. The mitral valve, however, poses further challenges. Contending with one of the heat’s most anatomically and pathologically complex components, practitioners and engineers have yet to perfect a stream-lined, widely deliverable therapy—though they are getting closer and closer to this goal.Transcatheter Mitral Valve Therapies provides a far-reaching survey of the field of mitral interventions in its current state. Highlighting the stumbling blocks preventing transcatheter mitral valve replacement’s widespread adoption, the book’s international group of contributors discuss the improvements to be made in repair and replacement procedures, as well as the adjunctive use of imaging and pharmacologic therapies. This ground-breaking text:Provides detailed explanations of transcatheter repair, transcatheter replacement, and adjunctive proceduresFeatures chapters on the use of imaging to aid in patient selection, procedure planning, and intra-operative guidanceDiscusses the importance of minimally invasive approaches for mitral valve repairExamines anticoagulation following transcatheter mitral valve interventionsOutlines the possible future of transcatheter mitral valve therapyTranscatheter Mitral Valve Therapies is an important, up-to-date resource for interventional cardiologists, as well as all clinical researchers and practitioners seeking information on this vital and developing treatment.

Understand and remedy chronic total occlusions with the third edition of this comprehensive guide

Chronic Total Occlusions offers the most comprehensive overview of chronic total occlusions (CTO) on the market, authored by two internationally recognized physician educators. It covers both the diagnostic modalities and treatment methods required to tailor a treatment program to individual cardiological patients with the greatest possible chance of success. Thorough and informed by the latest research and field data, the third edition of this guide is an indispensable resource for interventional cardiologists.

In Chronic Total Occlusions: A Guide to Recanalization, Third Edition, readers will also find:

Full-color images to guide diagnosis of CTOs Expert tips and tricks for key procedures involved in treating challenging cases Clinical case studies illustrating specific scenarios and frequently encountered complications

Chronic Total Occlusions: A Guide to Recanalization, Third Edition is a must-have for interventional cardiologists who want to maximize their patient outcomes.

Understand and remedy chronic total occlusions with the third edition of this comprehensive guide Chronic Total Occlusions offers the most comprehensive overview of chronic total occlusions (CTO) on the market, authored by two internationally recognized physician educators. It covers both the diagnostic modalities and treatment methods required to tailor a treatment program to individual cardiological patients with the greatest possible chance of success. Thorough and informed by the latest research and field data, the third edition of this guide is an indispensable resource for interventional cardiologists. In Chronic Total Occlusions: A Guide to Recanalization, Third Edition, readers will also find: Full-color images to guide diagnosis of CTOsExpert tips and tricks for key procedures involved in treating challenging casesClinical case studies illustrating specific scenarios and frequently encountered complicationsChronic Total Occlusions: A Guide to Recanalization, Third Edition is a must-have for interventional cardiologists who want to maximize their patient outcomes.

Understand and remedy chronic total occlusions with the third edition of this comprehensive guide

Chronic Total Occlusions offers the most comprehensive overview of chronic total occlusions (CTO) on the market, authored by two internationally recognized physician educators. It covers both the diagnostic modalities and treatment methods required to tailor a treatment program to individual cardiological patients with the greatest possible chance of success. Thorough and informed by the latest research and field data, the third edition of this guide is an indispensable resource for interventional cardiologists.

In Chronic Total Occlusions: A Guide to Recanalization, Third Edition, readers will also find:

Full-color images to guide diagnosis of CTOs Expert tips and tricks for key procedures involved in treating challenging cases Clinical case studies illustrating specific scenarios and frequently encountered complications

Chronic Total Occlusions: A Guide to Recanalization, Third Edition is a must-have for interventional cardiologists who want to maximize their patient outcomes.

Aortic Valve Transcatheter Intervention Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over.Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices.This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.

Aortic Valve Transcatheter Intervention

Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over.

Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices.

This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.

Aortic Valve Transcatheter Intervention

Calcific aortic stenosis (AS) is the most common heart valve anomaly, with a largely age-dependent prevalence, a calculated annual incidence rate in the range of 4-5% in general populations and up to 6% in patients aged 75 years and over.

Surgical aortic valve replacement (SAVR) was previously the only option available to patients with symptomatic, severe aortic stenosis. After the first-in-human transcatheter aortic valve implantation (TAVI) was performed by Alain Cribier in 2002, the treatment strategy for patients with symptomatic AS has been revolutionized. Since then, TAVI has grown exponentially, as a result of accruing evidence demonstrating safety and efficacy, and reduced invasiveness compared with SAVR. TAVI devices are continuously expanding to include several valve design options. As this strategy is continuously evolving to treat younger patients and lower-risk populations, aside from the long-term durability of the valve systems, procedural safety will become the focus of newer-generation devices.

This book is a practical handbook devoted to the optimization of TAVI procedures, through a focused containment of complications. Through an integrated evaluation of the clinical status, imaging techniques and laboratory findings, the authors provide readers with clear messages on preventive and therapeutic recommendations.

Cardiologists today prescribe medications with complex mechanisms of action, pharmacokinetics, indications, contraindications and drug-frug interactions; many of which were not available when today's practitioners were in training. This book was written to meet the growing demand for complete, detailed and accurate cardiac pharmacology information. This in-depth examination of the specific types of pharmacological agents used in the cardiac catheterization lab - as well as those routinely prescribed for cardiac patients - evaluates drugs with respect to their: Cellular and physiological actionsPrescribed usageDosagesAdverse reactionsCautionsCommon routes of administrationOpening chapters discuss anticoagulation therapies and antiplatelet therapies. later chapters cover percutaneous coronary intervention and its possible complications, post-procedure pharmacotherapy, and anticoagulation anomalies.Drawing on the expertise of contributors from around the world, Pharmacology in the Catheterization Laboratory is the perfect blend of evidence and experience.

Since publication of the First Edition, advances in the diagnosis and prevention and treatment strategies of the vulnerable plaque have necessitated this greatly expanded second edition. With several new chapters covering mainly diagnostic and treatment options, The Handbook of the Vulnerable Plaque will remain the benchmark text for all interventi

In this pathbreaking volume, a multidisciplinary team of international experts puts catheter–based treatment techniques in context by exploring the pathobiology of specific diseases alongside a discussion of imaging tools and functional tests, and a comparison to alternative treatment approaches provided by cardiovascular surgery.

This comprehensive overview of interventional cardiology: 

Explains treatments in depth, including imaging techniques and functional tests Serves as both a theoretical and practical guide to available treatment approaches that can be tailored for individual patients Provides the latest scientific data and new surgical alternatives Presents a practically oriented view of the most important interventional strategies Is written by a strong team of well-published and highly-regarded authors, the people whose breakthroughs in the clinic and the lab have made interventional cardiology the dynamic field it is today

Practitioners, fellows, and trainees who want a state-of-the-art guide to interventional cardiology can depend on this carefully crafted guide for authoritative information.

Here is expert guidance on one of the most vexing clinical challenges faced by interventional cardiologists. Written by global thought leaders in the area and edited by two internationally-recognized pioneers in interventional cardiology, Bifurcation Stenting covers all techniques, imaging modalities, and devices in current use, including VH-IVUS and OCT. It includes practical tips/tricks from leading experts and a section of challenging cases to further illustrate the material and help readers better understand the treatment of bifurcation lesions.

Here is expert guidance on one of the most vexing clinical challenges faced by interventional cardiologists. Written by global thought leaders in the area and edited by two internationally-recognized pioneers in interventional cardiology, Bifurcation Stenting covers all techniques, imaging modalities, and devices in current use, including VH-IVUS and OCT. It includes practical tips/tricks from leading experts and a section of challenging cases to further illustrate the material and help readers better understand the treatment of bifurcation lesions.

Here is expert guidance on one of the most vexing clinical challenges faced by interventional cardiologists. Written by global thought leaders in the area and edited by two internationally-recognized pioneers in interventional cardiology, Bifurcation Stenting covers all techniques, imaging modalities, and devices in current use, including VH-IVUS and OCT. It includes practical tips/tricks from leading experts and a section of challenging cases to further illustrate the material and help readers better understand the treatment of bifurcation lesions.